{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:08:53Z","timestamp":1790510933172,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003629","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T11:25:25Z","timestamp":1463138725000},"page":"e3629","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis"],"prefix":"10.1097","volume":"95","author":[{"given":"Tong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-53-20210309","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2169\/internalmedicine.49.4011","article-title":"Long-term efficacy of inhaled N-acetylcysteine in patients with idiopathic pulmonary fibrosis","volume":"49","author":"Bando","year":"2010","journal-title":"Intern Med"},{"key":"R2-53-20210309","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1465-9921-10-101","article-title":"Lung function in idiopathic pulmonary fibrosis-extended analyses of the IFIGENIA trial","volume":"10","author":"Behr","year":"2009","journal-title":"Respir Res"},{"key":"R3-53-20210309","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-53-20210309","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1440-1843.2012.02132.x","article-title":"Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis","volume":"17","author":"Homma","year":"2012","journal-title":"Respirology"},{"key":"R5-53-20210309","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez","year":"2014","journal-title":"N Engl J Med"},{"key":"R6-53-20210309","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1440-1843.2005.00725.x","article-title":"A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis","volume":"10","author":"Tomioka","year":"2005","journal-title":"Respirology"},{"key":"R7-53-20210309","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0300-2896(03)75457-X","article-title":"Diagnosis and treatment of diffuse interstitial lung diseases","volume":"39","author":"Xaubet","year":"2003","journal-title":"Arch Bronconeumol"},{"key":"R8-53-20210309","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1179\/oeh.2008.14.2.117","article-title":"Occupational risks for idiopathic pulmonary fibrosis mortality in the United States","volume":"14","author":"Pinheiro","year":"2008","journal-title":"Int J Occup Environ Health"},{"key":"R9-53-20210309","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1513\/pats.200512-131TK","article-title":"Is idiopathic pulmonary fibrosis an environmental disease?","volume":"3","author":"Taskar","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"R10-53-20210309","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","article-title":"Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis","volume":"184","author":"Lee","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-53-20210309","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MCP.0b013e3283567ff9","article-title":"The big clinical trials in idiopathic pulmonary fibrosis","volume":"18","author":"Luppi","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"R12-53-20210309","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur Respir J"},{"key":"R13-53-20210309","doi-asserted-by":"crossref","first-page":"e47024","DOI":"10.1371\/journal.pone.0047024","article-title":"Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"key":"R14-53-20210309","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1465-9921-14-S1-S6","article-title":"Recommendations on treatment for IPF","volume":"14","author":"Behr","year":"2013","journal-title":"Respir Res"},{"key":"R15-53-20210309","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/09031936.06.00010006","article-title":"Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled","volume":"27","author":"Wells","year":"2006","journal-title":"Eur Respir J"},{"key":"R16-53-20210309","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/ajrccm.152.3.7663783","article-title":"Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals","volume":"152","author":"Meyer","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-53-20210309","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1183\/09031936.94.07030431","article-title":"The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis","volume":"7","author":"Meyer","year":"1994","journal-title":"Eur Respir J"},{"key":"R19-53-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12016-010-8244-9","article-title":"Therapeutic update in idiopathic pulmonary fibrosis","volume":"44","author":"Chan","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"R20-53-20210309","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.arbres.2013.03.011","article-title":"Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR) Research Group on Diffuse Pulmonary Diseases","volume":"49","author":"Xaubet","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"R22-53-20210309","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1183\/09031936.00009112","article-title":"Triple therapy in idiopathic pulmonary fibrosis: an alarming press release","volume":"9","author":"Wells","year":"2012","journal-title":"Eur Respir J"},{"key":"R23-53-20210309","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/thoraxjnl-2011-201398","article-title":"Hot off the breath: triple therapy for idiopathic pulmonary fibrosis \u2013 hear the PANTHER roar","volume":"67","author":"McGrath","year":"2012","journal-title":"Thorax"},{"key":"R24-53-20210309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03256611","article-title":"Idiopathic pulmonary fibrosis: current and future treatment options","volume":"1","author":"Davies","year":"2002","journal-title":"Am J Respir Med"},{"key":"R25-53-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14656566.2013.758250","article-title":"The evolving pharmacotherapy of pulmonary fibrosis","volume":"14","author":"Lota","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R26-53-20210309","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000340041","article-title":"N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats","volume":"84","author":"Li","year":"2012","journal-title":"Respiration"},{"key":"R27-53-20210309","doi-asserted-by":"crossref","first-page":"L803","DOI":"10.1152\/ajplung.00283.2009","article-title":"Could N-acetylcysteine slow progression of idiopathic pulmonary fibrosis by inhibiting EMT?","volume":"297","author":"Wolters","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:24:25Z","timestamp":1620959065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201605100-00053"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":25,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003629","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}